COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether Fisetin, a senolytic drug, can assist in
preventing an increase in the disease's progression and alleviate complications of
coronavirus due to an excessive inflammatory reaction.